Development Funding. Tigercat will use [***] it receives under the Equity Agreements (the “Development Funding”) to fund the Development of Licensed Compounds and Licensed Products in accordance with the Development Plan. For the avoidance of doubt, amounts paid by Tigercat to VPD under the Services Agreement to design and manage the Development of the Licensed Compounds and Licensed Products shall be deemed to have been used to fund the Development of Licensed Compounds and Products in accordance with the Development Plan.
Appears in 3 contracts
Sources: Exclusive License Agreement (Menlo Therapeutics, Inc.), Exclusive License Agreement (Menlo Therapeutics, Inc.), Exclusive License Agreement (Menlo Therapeutics, Inc.)